FIELD: medicine; urology; oncology.
SUBSTANCE: invention can be used for differential diagnosis of acinar prostate adenocarcinoma 7=3+4 and 7=4+3 on the basis of bpMRI radiomics. Quantitative indices of bpMRI radiomics data obtained in LIFEx program are determined: DISCRETIZED_AUC_CSH, GLCM_Energy[=AngularSecondMoment], GLCMCorrelation, GLRLM_LRE, GLRLM_LGRE, GLRLM_SRHGE, GLZLM_LZE, GLZLM_LZLGE, GLZLM_LZHGE, GLZLM_ZLNU, SHAPE_Compacity[onlyFor3DROI], INFO_ActualFrameDuration, PARAMS_BoundsRangeOfV alueAfterDiscretisation_l. A prognostic CMR coefficient is calculated. If CMR>0.48, prostate acinar adenocarcinoma 7=3+4 according to Gleason is diagnosed. If CMR is ≤0.48, prostate acinar adenocarcinoma 7=4+3 according to Gleason is diagnosed.
EFFECT: method enables detecting prostate acinar adenocarcinoma 7=3+4 and 7=4+3 on the Gleason scale by bpMRI radiomics.
1 cl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREOPERATIVE DETERMINATION OF MORPHOLOGICAL RISK FACTORS FOR PROGRESSION IN PATIENTS WITH PROSTATE CANCER | 2021 |
|
RU2770983C1 |
| METHOD TO PERFORM A BIOPSY OF THE PROSTATE GLAND UNDER THE CONTROL OF ITS COMBINED IMAGES OBTAINED BY MAGNETIC RESONANCE IMAGING AND ULTRASOUND | 2018 |
|
RU2688373C1 |
| METHOD FOR PREDICTION OF AGGRESSIVE FORMS OF PROSTATE CANCER IN PATIENTS OF INTERMEDIATE AND HIGH RISK GROUP | 2021 |
|
RU2768477C1 |
| METHOD FOR PREDICTION OF RISK OF BIOCHEMICAL RECURRENT IN PROSTATE CANCER PATIENTS AFTER RADIATION AND HORMONE THERAPY | 2015 |
|
RU2605838C1 |
| METHOD OF TREATING PATIENTS WITH METASTASES IN LYMPH NODES AND OLIGOMETASTATIC DISEASE IN BONES OF SKELETON IN PROSTATE CANCER | 2018 |
|
RU2695348C2 |
| METHOD FOR PREDICTING THE CLINICAL STATUS OF PROSTATE CANCER | 2017 |
|
RU2664706C2 |
| DIAGNOSTIC METHOD OF CLINICALLY SIGNIFICANT PROSTATE CANCER | 2018 |
|
RU2681754C1 |
| METHOD FOR PROSTATE CANCER STAGE AND AGGRESSIVENESS PREDICTION PRIOR TO SURGERY, BASED ON LABORATORY AND CLINICAL PARAMETERS | 2015 |
|
RU2614501C1 |
| METHOD FOR DETERMINING THE RISK OF RECURRENCE OF LOCALIZED PROSTATE CANCER AFTER PERFORMING HIGH-INTENSITY FOCUSED ULTRASONIC ABLATION | 2018 |
|
RU2692681C1 |
| METHOD FOR ASSESSING DEGREE OF MALIGNANCY OF PROSTATIC ADENOCARCINOMA | 2019 |
|
RU2717944C1 |
